UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression

Seminars in Cancer Biology

Volumn 14, Issue 2, 2004, Pages 131-138

  Bachelor, Michael A ^a   Bowden, G Tim ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

AP 1; COX 2; IL 1 ; IL 8; JNK; p38; UVA; VEGF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NS 298; SP 600126; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; BENIGN TUMOR; CANCER CONTROL; CHEMOPROPHYLAXIS; ENZYME ACTIVATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN TUMOR; SOLAR RADIATION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR PROMOTION; ULTRAVIOLET A RADIATION;

EID: 1242295291     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2003.09.017     Document Type: Review

References (90)

1. Einspahr J.G., Stratton S.P., Bowden G.T., Alberts D.S. Chemoprevention of human skin cancer. Crit. Rev. Oncol. Hematol. 41:2002;269-285.
2. Kwa R.E., Campana K., Moy R.L. Biology of cutaneous squamous cell carcinoma. J. Am. Acad. Dermatol. 26:1992;1-26.
3. de Gruijl F.R. Photocarcinogenesis: UVA vs. UVB. Methods Enzymol. 319:2000;359-366.
4. Matsui M.S., DeLeo V.A. Longwave ultraviolet radiation and promotion of skin cancer. Cancer Cells. 3:1991;8-12.
5. Runger T.M. Role of UVA in the pathogenesis of melanoma and non-melanoma skin cancer. A short review. Photodermatol. Photoimmunol. Photomed. 15:1999;212-216.
6. de Laat A., van der Leun J.C., de Gruijl F.R. Carcinogenesis induced by UVA (365-nm) radiation: the dose-time dependence of tumor formation in hairless mice. Carcinogenesis. 18:1997;1013-1020.
7. Sterenborg H.J., van der Leun J.C. Tumorigenesis by a long wavelength UV-A source. Photochem. Photobiol. 51:1990;325-330.
8. Kelfkens G., de Gruijl F.R., van der Leun J.C. Tumorigenesis by short-wave ultraviolet A: papillomas versus squamous cell carcinomas. Carcinogenesis. 12:1991;1377-1382.
9. Matsui MS, DeLeo VA. Photocarcinogenesis by ultraviolet A and B. In: Mukhtar H, editor. Skin cancer: mechanisms and human relevance. Boca Raton, FL: CRC Press; 1995. p. 21-30.
10. Elmets CA. Cutaneous photocarcinogenesis. In: Mukhtar H, editor. Pharmacology of the skin. Boca Raton, FL: CRC Press; 1992. p. 389.
11. Soehnge H., Ouhtit A., Ananthaswamy O.N. Mechanisms of induction of skin cancer by UV radiation. Front. Biosci. 2:1997;D538-D551.
12. Silvers A.L., Bowden G.T. UVA irradiation-induced activation of activator protein-1 is correlated with induced expression of AP-1 family members in the human keratinocyte cell line HaCaT. Photochem. Photobiol. 75:2002;302-310.
13. Grether-Beck S., Bonizzi G., Schmitt-Brenden H., Felsner I., Timmer A., Sies H.et al. Non-enzymatic triggering of the ceramide signalling cascade by solar UVA radiation. EMBO J. 19:2000;5793-5800.
14. Darr D., Fridovich I. Free radicals in cutaneous biology. J. Invest. Dermatol. 102:1994;671-675.
15. Runger T. UV-light and carcinogenesis. In: Garbe CD, Kaufmann R, Tilgen, W, editors. Dermatologic oncology. Berline: Springer; 1997.
16. Applegate L.A., Luscher P., Tyrrell R.M. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res. 51:1991;974-978.
17. Cheng K.C., Cahill D.S., Kasai H., Nishimura S., Loeb L.A. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J. Biol. Chem. 267:1992;166-172.
18. Epe B. Genotoxicity of singlet oxygen. Chem. Biol. Interact. 80:1991;239-260.
19. Maki H., Sekiguchi M. MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis. Nature. 355:1992;273-275.
20. Bender K., Blattner C., Knebel A., Iordanov M., Herrlich P., Rahmsdorf H.J. UV-induced signal transduction. J. Photochem. Photobiol. B. 37:1997;1-17.
21. Ichihashi M., Ueda M., Budiyanto A., Bito T., Oka M., Fukunaga M.et al. UV-induced skin damage. Toxicology. 189:2003;21-39.
22. Thannickal V.J., Fanburg B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 279:2000;L1005-L1028.
23. Finkel T. Oxygen radicals and signaling. Curr. Opin. Cell Biol. 10:1998;248-253.
24. Rhee S.G. Redox signaling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 31:1999;53-59.
25. Cerutti P.A. Prooxidant states and tumor promotion. Science. 227:1985;375-381.
26. Girotti A.W. Photosensitized oxidation of membrane lipids: reaction pathways, cytotoxic effects, and cytoprotective mechanisms. J. Photochem. Photobiol. B. 63:2001;103-113.
27. Bachelor M.A., Silvers A.L., Bowden G.T. The role of p38 in UVA-induced cyclooxygenase-2 expression in the human keratinocyte cell line, HaCaT. Oncogene. 21:2002;7092-7099.
28. Klotz L.O., Pellieux C., Briviba K., Pierlot C., Aubry J.M., Sies H. Mitogen-activated protein kinase (p38, JNK, ERK) activation pattern induced by extracellular and intracellular singlet oxygen and UVA. Eur. J. Biochem. 260:1999;917-922.
29. Klotz L.O., Briviba K., Sies H. Singlet oxygen mediates the activation of JNK by UVA radiation in human skin fibroblasts. FEBS Lett. 408:1997;289-291.
30. Maziere C., Conte M.A., Leborgne L., Levade T., Hornebeck W., Santus R. et al. UVA radiation stimulates ceramide production: relationship to oxidative stress and potential role in ERK, JNK, and p38 activation. Biochem. Biophys. Res. Commun. 281:2001;289-294.
31. Zhang Y., Mattjus P., Schmid P.C., Dong Z., Zhong S., Ma W.Y.et al. Involvement of the acid sphingomyelinase pathway in uva-induced apoptosis. J. Biol. Chem. 276:2001;11775-11782.
32. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:1995;16483-16486.
33. Whitmarsh A.J., Davis R.J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74:1996;589-607.
34. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157.
35. Djavaheri-Mergny M., Mergny J.L., Bertrand F., Santus R., Maziere C., Dubertret L.et al. Ultraviolet-A induces activation of AP-1 in cultured human keratinocytes. FEBS Lett. 384:1996;92-96.
36. Djavaheri-Mergny M., Dubertret L. UV-A-induced AP-1 activation requires the Raf/ERK pathway in human NCTC 2544 keratinocytes. Exp. Dermatol. 10:2001;204-210.
37. Prescott S.M., Fitzpatrick F.A. Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta. 1470:2000;M69-M78.
38. Gresham A., Masferrer J., Chen X., Leal-Khouri S., Pentland A.P. Increased synthesis of high-molecular-weight cPLA2 mediates early UV-induced PGE2 in human skin. Am. J. Physiol. 270:1996;C1037-C1050.
39. Hanson D., DeLeo V. Long-wave ultraviolet light induces phospholipase activation in cultured human epidermal keratinocytes. J. Invest. Dermatol. 95:1990;158-163.
40. Kang-Rotondo C.H., Miller C.C., Morrison A.R., Pentland A.P. Enhanced keratinocyte prostaglandin synthesis after UV injury is due to increased phospholipase activity. Am. J. Physiol. 264:1993;C396-C401.
41. Soriani M., Rice-Evans C., Tyrrell R.M. Modulation of the UVA activation of haem oxygenase, collagenase and cyclooxygenase gene expression by epigallocatechin in human skin cells. FEBS Lett. 439:1998;253-257.
42. Dean J.L., Brook M., Clark A.R., Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274:1999;264-269.
43. Lasa M., Mahtani K.R., Finch A., Brewer G., Saklatvala J., Clark A.R. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell Biol. 20:2000;4265-4274.
44. Ridley S.H., Dean J.L., Sarsfield S.J., Brook M., Clark A.R., Saklatvala J. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett. 439:1998;75-80.
45. Zhang Z., Sheng H., Shao J., Beauchamp R.D., DuBois R.N. Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells. Neoplasia. 2:2000;523-530.
46. Winzen R., Kracht M., Ritter B., Wilhelm A., Chen C.Y., Shyu A.B.et al. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18:1999;4969-4980.
47. Cok S.J., Morrison A.R. The 3′-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J. Biol. Chem. 276:2001;23179-23185.
48. Dixon D.A., Kaplan C.D., McIntyre T.M., Zimmerman G.A., Prescott S.M. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J. Biol. Chem. 275:2000;11750-11757.
49. Dixon D.A., Tolley N.D., King P.H., Nabors L.B., McIntyre T.M., Zimmerman G.A.et al. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Invest. 108:2001;1657-1665.
50. Nabors L.B., Gillespie G.Y., Harkins L., King P.H. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res. 61:2001;2154-2161.
51. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1971;1182-1186.
52. Conti C.J. Vascular endothelial growth factor: regulation in the mouse skin carcinogenesis model and use in antiangiogenesis cancer therapy. Oncologist. 7(Suppl. 3):2002;4-11.
53. Casanova M.L., Larcher F., Casanova B., Murillas R., Fernandez-Acenero M.J., Villanueva C.et al. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Cancer Res. 62:2002;3402-3407.
54. Larcher F., Franco M., Bolontrade M., Rodriguez-Puebla M., Casanova L., Navarro M.et al. Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis. Mol. Carcinog. 37:2003;83-90.
55. Bolontrade M.F., Stern M.C., Binder R.L., Zenklusen J.C., Gimenez-Conti I.B., Conti C.J. Angiogenesis is an early event in the development of chemically induced skin tumors. Carcinogenesis. 19:1998;2107-2113.
56. Quintanilla M., Brown K., Ramsden M., Balmain A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature. 322:1986;78-80.
57. Brown K., Buchmann A., Balmain A. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc. Natl. Acad. Sci. U.S.A. 87:1990;538-542.
58. Larcher F., Murillas R., Bolontrade M., Conti C.J., Jorcano J.L. VEGF/ VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene. 17:1998;303-311.
59. Bernstein L.R., Colburn N.H. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science. 244:1989;566-569.
60. Domann F.E. Jr., Levy J.P., Finch J.S., Bowden G.T. Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol. Carcinog. 9:1994;61-66.
61. Garssen J., van Loveren H. Effects of ultraviolet exposure on the immune system. Crit. Rev. Immunol. 21:2001;359-397.
62. Corsini E., Sangha N., Feldman S.R. Epidermal stratification reduces the effects of UVB (but not UVA) on keratinocyte cytokine production and cytotoxicity. Photodermatol. Photoimmunol. Photomed. 13:1997;147-152.
63. Marshall V. Premalignant and malignant skin tumours in immunosuppressed patients. Transplantation. 17:1974;272-275.
64. Kondo S., Jimbow K. Dose-dependent induction of IL-12 but not IL-10 from human keratinocytes after exposure to ultraviolet light A. J. Cell Physiol. 177:1998;493-498.
65. Yarosh D.B. The role of DNA damage and UV-induced cytokines in skin cancer. J. Photochem. Photobiol. B. 16:1992;91-94.
66. Kondo S. The roles of keratinocyte-derived cytokines in the epidermis and their possible responses to UVA-irradiation. J. Investig. Dermatol. Symp. Proc. 4:1999;177-183.
67. Shen J., Bao S., Reeve V.E. Modulation of IL-10, IL-12, and IFN-gamma in the epidermis of hairless mice by UVA (320-400 nm) and UVB (280-320 nm) radiation. J. Invest. Dermatol. 113:1999;1059-1064.
68. Chen Z., Colon I., Ortiz N., Callister M., Dong G., Pegram M.Y.et al. Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines. Cancer Res. 58:1998;3668-3676.
69. Wolf J.S., Chen Z., Dong G., Sunwoo J.B., Bancroft C.C., Capo D.E.et al. IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin. Cancer Res. 7:2001;1812-1820.
70. Vile G.F., Tanew-Ilitschew A., Tyrrell R.M. Activation of NF-kappa B in human skin fibroblasts by the oxidative stress generated by UVA radiation. Photochem. Photobiol. 62:1995;463-468.
71. Sanchez Ruderisch H., Schwarz C., Shang J., Tebbe B. Trioxsalen in the presence of UVA is able to induce nuclear factor kappa B binding activity in HaCaT keratinocytes. Skin Pharmacol. Appl. Skin Physiol. 15:2002;335-341.
72. Shang J., Schwarz C., Sanchez Ruderisch H., Hertting T., Orfanos C.E., Tebbe B. Effects of UVA and L-ascorbic acid on nuclear factor-kappa B in melanocytes and in HaCaT keratinocytes. Skin Pharmacol. Appl. Skin Physiol. 15:2002;353-359.
73. Djavaheri-Mergny M., Gras M.P., Mergny J.L., Dubertret L. UV-A-induced decrease in nuclear factor-kappaB activity in human keratinocytes. Biochem. J. 338(Pt 3):1999;607-613.
74. Wang X., Gjernes E., Prydz H. Factor VIIa induces tissue factor-dependent up-regulation of interleukin-8 in a human keratinocyte line. J. Biol. Chem. 277:2002;23620-23626.
75. Bancroft C.C., Chen Z., Yeh J., Sunwoo J.B., Yeh N.T., Jackson S.et al. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int. J. Cancer. 99:2002;538-548.
76. Chen Z., Malhotra P.S., Thomas G.R., Ondrey F.G., Duffey D.C., Smith C.W.et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin. Cancer Res. 5:1999;1369-1379.
77. Bancroft C.C., Chen Z., Dong G., Sunwoo J.B., Yeh N., Park C.et al. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. Clin. Cancer Res. 7:2001;435-442.
78. Turini M.E., DuBois R.N. Cyclooxygenase-2: a therapeutic target. Annu. Rev. Med. 53:2002;35-57.
79. An K.P., Athar M., Tang X., Katiyar S.K., Russo J., Beech J.et al. Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches. Photochem. Photobiol. 76:2002;73-80.
80. Kagoura M., Toyoda M., Matsui C., Morohashi M. Immunohistochemical expression of cyclooxygenase-2 in skin cancers. J. Cutan. Pathol. 28:2001;298-302.
81. Thompson E.J., Gupta A., Vielhauer G.A., Regan J.W., Bowden G.T. The growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1. Neoplasia. 3:2001;402-410.
82. Tiano H.F., Loftin C.D., Akunda J., Lee C.A., Spalding J., Sessoms A.et al. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res. 62:2002;3395-3401.
83. Fischer S.M., Lo H.H., Gordon G.B., Seibert K., Kelloff G., Lubet R.A.et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol. Carcinog. 25:1999;231-240.
84. Pentland A.P., Schoggins J.W., Scott G.A., Khan K.N., Han R. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis. 20:1999;1939-1944.
85. Reeve V.E., Matheson M.J., Bosnic M., Boehm-Wilcox C. The protective effect of indomethacin on photocarcinogenesis in hairless mice. Cancer Lett. 95:1995;213-219.
86. Futagami A., Ishizaki M., Fukuda Y., Kawana S., Yamanaka N. Wound healing involves induction of cyclooxygenase-2 expression in rat skin. Lab. Invest. 82:2002;1503-1513.
87. Strieth S., Hartschuh W., Pilz L., Fusenig N.E. Angiogenic switch occurs late in squamous cell carcinomas of human skin. Br. J. Cancer. 82:2000;591-600.
88. Joo Y.E., Rew J.S., Seo Y.H., Choi S.K., Kim Y.J., Park C.S.et al. Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer. J. Clin. Gastroenterol. 37:2003;28-33.
89. Gallo O., Franchi A., Magnelli L., Sardi I., Vannacci A., Boddi V.et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia. 3:2001;53-61.
90. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., DuBois R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 93:1998;705-716.